We are a Canadian oncology CRO with a singular focus on oncology. We play a vital role in improving the speed and efficiency of oncology clinical research through a deep understanding of the needs of sponsors, investigators and patients. Our mission is to improve site selection and patient recruitment, and speed up clinical trials by attracting cutting-edge oncology compounds and clinical trials to Canada. The Reverse Feasibility Program is designed to connect small and mid-sized biopharma companies with a network of highly motivated investigators and their patients. We believe that the rise of targeted therapies and personalized medicine should not increase operational complexity or compromise the efficiency of clinical trials.